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Parasites have kept many secrets from the researchers who have
sought to eradicate them over past decades. The mechanisms by
which they evade drugs, escape the immune system, regulate
switching between genes involved in immune evasion, and
orchestrate development have been difficult to elucidate. They
have been successful at this in part because they are difficult to keep
in the laboratory, difficult to breed, and difficult to raise in sufficient
quantities for biochemistry, and because they parasitize hosts that
are not ideal experimental subjects. While Plasmodium falciparum is
less tractable than one would wish, genetic manipulation can still be
performed. On the other hand, Plasmodium vivax, which cannot be
maintained in culture, is even less accessible, and there are few
research tools available.
While these difficulties present impediments to drug, vaccine, and
basic research, the availability of parasite genome sequences and
related genome-based tools have provided substantial opportunities
toovercomethelackofarobustculturesystemneededfortraditional
molecular biology, the shortage of material for biochemistry, and the
lack of traditional genetic methods for studying gene function. The
advent of new technologies for examining and detecting genetic
variation, measuring transcript abundance, and measuring protein
or metabolite abundance on a genome-wide scale, or for sequencing
genomes in combination with new computational methods, may lift
some of the barriers to working on actual pathogens. Here, I will
review some recent discoveries that were facilitated by industrial-
scale molecular biology approaches.
New Genome Sequences
The year 2008 witnessed the publication of the complete genome
sequence of P. vivax as well as that of Plasmodium knowlesi [1,2].
Although P. vivax may be responsible for up to 40% of the 515
million malaria cases each year, work on this parasite has generally
lagged because it cannot yet be maintained in long-term culture.
Among the highlights of the P. vivax genome sequence was the
observation that it encodes a variety of cell-binding proteins
involved in erythrocyte selection, and thus P. vivax may be able to
use a variety of red cell invasion strategies. Of course, knowing the
complement of genes encoded by a genome only serves as a prelude
to further functional studies, and the first set of gene expression data
for P. vivax was published soon afterwards [3]. This work showed
that the transcriptional program of P. vivax is similar to that of P.
falciparum and offers hypotheses about the function of a variety of P.
vivax genes. For example, a gene whose transcriptional pattern is
correlated with those of known invasion genes may also be involved
in invasion. Accompanying the publication on the P. vivax genome
was the sequence of P. knowlesi, described as the fifth human
pathogen given its documented zoonoses [4]. This genome
sequence reveals intriguing examples of molecular mimicry [2]. It
was shown that members of the multigene family encoding the KIR
proteins have a predicted extracellular domain that shows stretches
of identity to host proteins with particularly strong matches to
CD99, a human immunoregulatory protein found on the surface of
T cells and other lymphocytes. These data raise the interesting
possibility that the kir gene products may play a more active role in
immune suppression through competition with T cells for CD99
partner molecules rather than just functioning as an antigenic
smokescreen, a presumed role for many of the proteins encoded by
highly variable Plasmodium multigene families (vars, stevors, virs).
Genetic Regulatory Networks
In organisms that are relatively difficult to genetically
manipulate, genomic methods offer opportunities to define
regulatory networks by linking motifs in the promoters of co-
expressed genes to the DNA-binding activity of different
transcription factors. It was recently shown that sets of co-
transcribed genes in P. falciparum often share short sequence motifs
upstream of their ATGs at rates not expected by chance [5]. A
similar approach has been shown to work in Toxoplasma gondii,
where functional annotations served as a substitute for gene
expression groupings [10]. Although site-directed mutagenesis in
P. falciparum has validated the importance of some of these motifs
controlling promoter activity, the identity of proteins that bind
these motifs has remained generally obscure. However, recently de
Silva and coworkers used a protein-binding microarray that
contains every possible 10-mer [6] to discover the motifs bound by
a series Apicomplexan AP2 transcription factors [7]. These are
members of a putative transcription factor family discovered by
bioinformatic searches and are homologous to a family in
Arabidopsis named the AP2/ERF DNA-binding family [8].
Remarkably, several of these motifs were near perfect matches
to the set of motifs shown to be associated with genes involved in
invasion or exoerythrocytic stage function in the transcriptional
analysis [5]. Moreover, Yuda and coworkers provided genetic
confirmation that one of the AP2 proteins regulates genes
expressed in the ookinete stage [9] by binding to specific six-base
sequences in the proximal promoter. The next challenge will be to
perform chromatin immunoprecipitation studies on all DNA-
binding proteins and to examine their genome-wide occupancy
with a goal of creating a complete map.
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While specific promoter elements are likely to regulate some
genes, chromatin structure may play a major role in controlling
transcription of genes involved in antigenic variation in multiple
parasite species. Malaria parasites and trypanosomes both have
large sets of genes that are involved in antigenic variation, and
while the two species are well separated on the tree of life,
epigenetics appear to control expression of genes involved in
antigenic variation in both species. In African trypanosomes, it was
shown that a particular histone methylase is responsible in
repressing variant surface glycoprotein genes involved in antigenic
variation [11]. In malaria parasites, disrupting the histone
deacetylase PfSir2A, but not PfSir2B, also results in derepression
of genes involved in antigenic variation [12]. Genome-wide
chromatin immunoprecipitation studies have also shown correla-
tions between various histone modifications [13,14], or P.
falciparum heterochromatin protein 1 [15] and the location of
clonally variant gene families in P. falciparum. Likewise, histone
variants mark the start of polycistronic Pol II transcripts in
trypanosomes [16]. The patterns of histone occupancy and
modification may lead to new theories for how the regulation
and switching of antigenic variation genes, critical to pathogenesis,
are controlled.
Expression Quantitative Trait Loci
Sexual crosses can be difficult to perform in parasites.
Nevertheless, laboratory crosses have been performed on several
occasions for T. gondii and P. falciparum. The resulting progeny have
been used to map genes involved in drug resistance, host specificity
[3], and virulence. While the crosses were usually set up to map a
particular trait (e.g., chloroquine resistance), the progeny strains
can also be used to map the locus responsible for any quantitative
phenotypic difference that separates the two parental lines. Such
phenotypes may include growth rate, host cell invasion pattern,
differences in the immunolocalization pattern of a given marker,
or even gene expression differences [17] that are mapped using a
method called expression quantitative trait locus (eQTL) mapping.
eQTL work involves the use of linkage mapping to locate genome
regions that determine transcript abundance. Both cis loci and trans
loci can be identified. An allele that gives rise to a cis eQTL might
affect transcript abundance for just that gene by affecting
promoter activity or transcript degradation rates, while a trans
eQTL, potentially in a transcription factor or an RNA-binding
protein, might affect the transcript levels at a variety of unlinked
loci. By examining the full genome expression profile of different
progeny from a genetic cross, one can determine potential
regulatory loci shared by all strains having the same expression
phenotype (Figure 1). In P. falciparum, expression studies were
performed on a series of progeny clones from a genetic cross
between a chloroquine-resistant strain (Dd2) and chloroquine-
sensitive strain (HB3) [18]. The authors of this paper identified a
powerful trans eQTL on chromosome 5 that controls expression at
a large number of genes across the genome and co-localizes with
an important drug resistance gene (pfmdr1). However, similar
studies using the progeny of a genetic cross between a virulent and
Figure 1. Expression quantitative locus (eQTL) mapping. In this method, different clones from a genetic cross are expression profiled,
potentially resulting in two or more different groups, which show distinct expression patterns for a variety of genes as represented by the red-green
heat map. Genotyping is then performed on the clones. Loci are identified that are shared by all the clones with the group A pattern, but not by
clones with the group B pattern (hypothetical data). The locus may encode a transcriptional regulatory protein that controls the expression of a
variety of different genes.
doi:10.1371/journal.ppat.1000649.g001
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indicating that virulence differences were likely to be in
polymorphic genes [19] and not in any regulatory factor. Because
different host strains are known to be more or less susceptible to
parasite infection, the same approach could be used to map
regulatory genes controlling the host’s response to infection by
examining expression profiles of white blood cells or in affected
organs in susceptible and nonsusceptible hosts.
Translating Genomics into Drug Discovery
Over the past several years, the problem of rapidly emerging
drug resistance has led to substantial investments in drug discovery
programs that have sought to place new drugs for neglected
diseases into the pipeline. Drug discovery efforts have benefited
from genome sequencing programs that have revealed targets that
are found in parasites but are lacking in humans. However, an
additional and potentially unrecognized benefit of having parasite
genome sequences is that they offer a very powerful approach for
rapidly determining an uncharacterized drug’s likely mechanism
of action or target using in vitro evolution studies. This classic
method, which involves growing microbes in sub-lethal concen-
trations of a drug until they become resistant and then mapping
the mutant allele through complementation, has been available to
bacteriologists for many years. Because parasites may lack efficient
complementation methods, parasitologists have had to wait for the
advent of full genome sequencing or the availability of compre-
hensive full genome tiling arrays to use this approach. Recently,
Dharia et al. showed that tiling microarrays, in addition to uses in
discovering new transcripts [20] or characterizing variation [21],
could be used to detect a copy number variant responsible for
fosmidomycin resistance and a newly emerged point mutation
responsible for blasticidin resistance [22]. Full genome deep
sequencing methods also may give similar results and may be the
only option for diploid organisms. Copy number variants or SNPs
discovered in the laboratory and associated with drug resistance
may eventually be examined in the field. Nair et al. examined
linkage disequilibrium with a previously identified copy number
variant and showed that GTP cyclohydrolase I amplifications are
in linkage disequilibrium with key drug resistance mutations in
dihydrofolate reductase [23], suggesting a functional linkage
between these two genes.
The frontier of parasite genomics is probably not in sequencing
more parasite species or in collecting gene expression data from
another pair of conditions. Advances are more likely to be through
the integration of large multifaceted datasets, and through studies
of complex systems, such as the global transcriptome of the
parasite in immune and nonimmune patients, or susceptible and
nonsusceptible inbred mice lines. In addition, there are great
opportunities for combining population biology with genomics.
One could imagine in the future pinpointing the molecular basis of
drug resistance through eQTL mapping using expression profiles
of parasites obtained from the blood of individuals who had
clinically failed treatment. Before this can be realized, however,
similar advances in methods for phenotyping parasites will need to
be developed. Nevertheless, it seems likely the impact of genomics
will soon be measured at the bedside.
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